n acute myocardial infarction (AMI), early, complete and sustained restoration of blood flow in the occluded coronary artery can salvage myocardium at risk and improve survival. 1 Revascularization of the occluded coronary artery with balloon angioplasty can be achieved in >90% of patients. 2 However, even early restoration of thrombolysis-in-myocardial-infarction (TIMI) grade 3 flow is not always associated with myocardial reperfusion because of microvascular damage. [3] [4] [5] [6] [7] Recent studies have demonstrated that persistent ST segment elevation after revascularization is a marker of impaired microvascular reperfusion 8 and is associated with a worse clinical outcome. [9] [10] [11] [12] Intraaortic balloon pumping (IABP), which can reduce the rate of infarct-related artery reocclusion, augment myocardial recovery and improve clinical outcome after AMI, 13,14 would be expected to be most effective in AMI patients with persistent ST segment elevation after revascularization.
anterior descending artery; (5) TIMI grade 3 and postprocedural diameter stenosis <50% after revascularization; (6) persistent ST segment elevation after revascularization; and (7) left ventriculography carried out before revascularization and at follow-up. Twelve-lead ECGs were recorded just before revascularization and on return to the coronary care unit. The sum of ST segment elevation was measured 20 ms after the end of the QRS complex from leads I, aVL and V1-6. Patients with a bundle branch block or persistent ventricular arrhythmia were excluded. Persistent ST segment elevation after revascularization was defined as ≥50% of the initial value on return to the coronary care unit (Fig 1) . 9, 11 Patients were excluded if they had cardiogenic shock, hypotension (systolic blood pressure <90 mmHg) unresponsive to intravenous fluids or pressor therapy, or pulmonary edema requiring IABP, because the goal of the current study was to assess the impact of IABP on left ventricular function in patients with uncomplicated AMI and persistent ST segment elevation.
Cardiac Catheterization
After intravenous infusion of 5,000 U of heparin, left ventriculography and coronary angiography were performed by the femoral or brachial approach. Left ventriculography was performed in a 30-degree right anterior oblique projection. The left ventricular ejection fraction (LVEF) and enddiastolic and end-systolic volumes were measured by 2 independent technicians using the area -length method. Coronary angiography was performed after an intracoronary infusion of nitroglycerin, and collateral vessels were graded according to Rentrop's classification. 15 Multivessel disease was defined as the presence of a lesion with ≥75% stenosis in a non-infarct-related artery. Conventional balloon angioplasty aimed to obtain a residual stenosis of <50% and restoration of brisk anterograde flow. Since 1995, coronary stenting has been performed if appropriate. The modality of treatment was not randomized, and was based on the physician's decision. All patients were treated with aspirin (81 mg/day) and after stenting were treated with ticlopidine (minimum dosage 100 mg/day) for 4 weeks. Follow-up angiography was performed 4-6 months later.
IABP Insertion
All IABP were inserted by a cardiologist experienced with the percutaneous insertion technique. A 10.5F balloon catheter was inserted via the femoral artery, and the IABP was usually inserted after the final image of acute angiography. The IABP was continued for approximately 24 h at a rate of 1:1, and the patient was gradually weaned from the pump during 3 h before removal of the catheter. The use of IABP was based on the physician's decision.
Measurements of Creatine Kinase Concentration
In order to determine the peak creatine kinase concentration, blood samples were obtained every 3 h during the first 24 h and then once daily from the second day until a normal value was obtained.
Statistical Analysis
Data are presented as mean ± SD. Within-group comparisons were obtained using paired t-test, and between-group comparisons using unpaired t-test. Categoric variables were analyzed by the chi-squared test. A p value <0.05 was considered to be statistically significant in all cases.
Results

Baseline Characteristics
A total of 51 patients were enrolled: 24 were treated without IABP (control group) and 27 were treated with IABP for 22±4 h (IABP group). Baseline clinical and angiographic variables are shown in Table 1 . There was no significant difference in age or gender; prevalence of diabetes, hypertension, hypercholesterolemia, smoking, previous angina, multivessel disease, collateral circulation, or time to reperfusion. Coronary stenting was performed more frequently in the control group (83% vs 48%, p<0.01). No major complications occurred with the IABP procedure. There was no significant difference between the 2 groups in the frequency of administration of nitrates or angiotensinconverting enzyme inhibitors (ACEI). Peak creatine kinase concentration was obtained in all patients and averaged 3,969±2,066 IU/L in the control group and 4,434± 2,505 IU/L in the IABP group (p=0.48).
Ventricular Function
There was no significant difference in pretreatment LVEF between the 2 groups (49±10% vs 49±8%, p=0.89). Follow-up angiography was carried out 137±46 days after AMI at which time the incidence of TIMI grade 3 did not differ between the 2 groups (100% vs 93%, p=0.28). There was a tendency toward a higher LVEF at follow-up in the IABP group (54±15% vs 62±14%, p=0.06), and changes in LVEF were significantly higher in the IABP group than in the control group (5±13% vs 13±15%, p=0.04) (Fig 2) . There was no significant difference in left ventricular enddiastolic volume index during the follow-up between the 2 groups (pretreatment: 77±19 ml/m 2 vs 74±13 ml/m 2 , p= 0.54; follow-up: 86±22 ml/m 2 vs 83±18 ml/m 2 , p=0.60) (Fig 3) .
There was no significant difference in pretreatment left ventricular end-systolic volume index between the 2 groups (40±15 ml/m 2 vs 38±9 ml/m 2 , p=0.61). There was a tendency toward a smaller left ventricular end-systolic volume index at follow-up in the IABP group (42±22 ml/m 2 vs 32±17 ml/m 2 , p=0.08) (Fig 4) .
Discussion
Present Findings
The major finding of the present study was that IABP enhanced the improvement in LVEF independent of remodeling in AMI patients with persistent ST segment elevation after revascularization.
Previous Studies
Coronary angioplasty is an effective reperfusion strategy, with early restoration of adequate coronary flow occurring in >90% of AMI patients; 2 however, despite successful revascularization, a substantial number of patients still fail to obtain complete and sustained myocardial reperfusion. Previous studies with myocardial contrast echocardiography have revealed zones of impaired tissue flow, termed the 'no-reflow' phenomenon, in one-quarter to one-third of reperfused AMI patients, [3] [4] [5] and this is accompanied by ST segment elevation on the 12-lead ECG. 16, 17 Several studies have examined the implication of persistent ST segment elevation as a marker of impaired microvascular reperfusion for prognosis after AMI. 8 Claeys et al reported that impaired microvascular reperfusion, as evidenced by persistent ST segment elevation after successful revascularization (≥50% of the initial value), was observed in more than one-third of AMI patients, and was associated with more extensive infarction and a worse clinical outcome. 9 Moreover, van't Hof et al 10 and Matetzky et al 11 reported that persistent ST segment elevation was associated with worse recovery of left ventricular function. Although we have previously reported the ability of IABP to augment myocardial recovery after revascularization for AMI, 13, 18 there are no published data specifically focusing on the impact of IABP in AMI patients with persistent ST segment elevation and to our knowledge, the present study is the first to do so.
Ventricular Function
In the current study, we only included patients admitted within 6 h of the onset of their first anterior AMI. In addition, we excluded patients with cardiogenic shock or pulmonary edema requiring IABP, because the goal of the current study was to assess the impact of IABP on left ventricular function in patients with uncomplicated AMI and persistent ST segment elevation. As previously reported, the change in LVEF is minimal in AMI patients with persistent ST segment elevation who are not treated with IABP; [10] [11] [12] however, in the present patients treated with IABP, significant improvement in LVEF was obtained during the follow-up period. Previous studies have demonstrated that infarct-related artery patency is an important determinant of ventricular remodeling after AMI. 19, 20 In the current study, the incidence of TIMI grade 3 at follow-up did not differ between the 2 groups. In addition, it is noteworthy that the use of medications, such as nitrates 21 and ACEI, which might prevent ventricular remodeling after AMI, were similar between the 2 groups. 22, 23 In the current study, there was no significant difference in left ventricular end-diastolic volume index between the 2 groups during the follow-up period, which suggested that in AMI patients with persistent ST segment elevation, IABP enhanced the improvement in LVEF independent of remodeling.
Proposed Mechanism
There are several physiologic effects of IABP that may explain the improvement in LVEF in patients with persistent ST segment elevation. 24 First, IABP augments diastolic arterial pressure, which is an important determinant of the coronary driving pressure. We have previously demonstrated that IABP increases peak coronary blood flow velocity in patients after coronary angioplasty for anterior AMI. 25 A second possible mechanism is based on decreasing the systolic arterial pressure and left ventricular end-diastolic pressure, which then decreases the myocardial oxygen demand. These favorable hemodynamic effects of IABP may contribute to attenuation of impaired microvascular circulation and result in a reduced myocardial infarct. In the current study, infarct size assessed by peak creatine kinase concentration was similar between the 2 groups, possibly because increased washout of creatine kinase associated with improved perfusion by IABP might have been effected. 26 There are several possible reasons why IABP could not prevent left ventricular remodeling in AMI patients with persistent ST segment elevation despite its favorable hemodynamic effects. First, the effect of left ventricular unloading obtained by IABP may be too small; ventricular remodeling is influenced not only by ventricular load, but also by other factors such as neurohormonal activation or local tissue growth factors. 27 Second, the duration of IABP in the present study may have been too short; ventricular remodeling continues for weeks or months until the distending forces are counterbalanced by the tensile strength of the collagen scar.
Study Limitations
The present study suffers from the limitations common to all nonrandomized, retrospective analyses. First, the allocation of revascularization strategy and the use of IABP were based on the physician's decision. Because IABP was performed, in part, to prevent abrupt vessel closure after revascularization, coronary stenting resulted in IABP being used less frequently. 13, 18 However, it is noteworthy that incidence of persistent ST segment elevation after revascularization was similar between balloon angioplasty and coronary stenting in the present patients. 28 Second, we assessed myocardial infarct size only by peak creatine kinase concentration, and superior results may heve been obtained from myocardial scintigraphy. Third, the small sample size is a major limitation and a larger study should be performed to confirm our findings.
Conclusions
In AMI patients with persistent ST segment elevation after revascularization, IABP enhances the improvement in LVEF independent of remodeling. Our data emphasize the importance of hemodynamic support under these conditions.
